Michael Brunsteiner

Michael Brunsteiner

Auto-generated profile, based on publicly available information

Michael Brunsteiner

Research Center Pharmaceutical Engineering GmbH (RCPE), 8010 Graz, Austria

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SVSubash Velaparthi
Subash Velaparthi
MBMichael Brunsteiner
Michael Brunsteiner
RUReaz Uddin
Reaz Uddin
BWBaojie Wan
Baojie Wan
SFScott Franzblau
Scott Franzblau
PPPavel A. Petukhov
Pavel A. Petukhov

6 May 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RNRaghupathi Neelarapu
Raghupathi Neelarapu
DHDenise L. Holzle
Denise L. Holzle
SVSubash Velaparthi
Subash Velaparthi
HBHe Bai
He Bai
MBMichael Brunsteiner
Michael Brunsteiner
PPPavel A. Petukhov
Pavel A. Petukhov

15 September 2004 in Crystal Growth & Design
Verified
Journal Article
Closed access
MBMichael Brunsteiner
Michael Brunsteiner
AJAlan G. Jones
Alan G. Jones
FPFederica Pratola
Federica Pratola
SPSarah L. Price
Sarah L. Price
SSStefaan J. R. Simons
Stefaan J. R. Simons

1 September 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TEThomas Eixelsberger
Thomas Eixelsberger
SSSabine Sykora
Sabine Sykora
SESigrid Egger
Sigrid Egger
MBMichael Brunsteiner
Michael Brunsteiner
KKKathryn L. Kavanagh
Kathryn L. Kavanagh
BNBernd Nidetzky
Bernd Nidetzky
UDP-xylose synthase (UXS) catalyzes decarboxylation of UDP-d-glucuronic acid to UDP-xylose. In mammals, UDP-xylose serves to initiate glycosaminoglycan synthesis on the protein core of extracellular matrix proteoglycans. Lack of UXS activity leads to a defective extracellular matrix, resulting in strong interference with cell signaling pathways. We present comprehensive structural and mechanistic characterization of the human form of UXS. The 1.26-Å crystal structure of the enzyme bound with NAD+ and UDP reveals a homodimeric short-chain dehydrogenase/reductase (SDR), belonging to the NDP-sugar epimerases/dehydratases subclass. We show that enzymatic reaction proceeds in three chemical steps via UDP-4-keto-d-glucuronic acid and UDP-4-keto-pentose intermediates. Molecular dynamics simulations reveal that the d-glucuronyl ring accommodated by UXS features a marked 4C1 chair to BO,3 boat distortion that facilitates catalysis in two different ways. It promotes oxidation at C4 (step 1) by aligning the enzymatic base Tyr147 with the reactive substrate hydroxyl and it brings the carboxylate group at C5 into an almost fully axial position, ideal for decarboxylation of UDP-4-keto-d-glucuronic acid in the second chemical step. The protonated side chain of Tyr147 stabilizes the enolate of decarboxylated C4 keto species (2H1 half-chair) that is then protonated from the Si face at C5, involving water coordinated by Glu120. Arg277, which is positioned by a salt-link interaction with Glu120, closes up the catalytic site and prevents release of the UDP-4-keto-pentose and NADH intermediates. Hydrogenation of the C4 keto group by NADH, assisted by Tyr147 as catalytic proton donor, yields UDP-xylose adopting the relaxed 4C1 chair conformation (step 3).


3 November 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BHBai He
Bai He
SVSubash Velaparthi
Subash Velaparthi
GPGilles Pieffet
Gilles Pieffet
CPChris Pennington
Chris Pennington
AMAruna Mahesh
Aruna Mahesh
PPPavel A. Petukhov
Pavel A. Petukhov